Methotrexate-potent cancer chemotherapeutic agent


Methotrexate, a potent cancer chemotherapeutic agent, is a strong competitive inhibitor of the dihydrofolate reductase. Explain why this compound is an efficient inhibitor of the de novo synthesis of both purine and thymidine nucleotides.

Request for Solution File

Ask an Expert for Answer!!
Biology: Methotrexate-potent cancer chemotherapeutic agent
Reference No:- TGS036641

Expected delivery within 24 Hours